Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

IQVIA controls one of the world's largest databases of healthcare information that's closely integrated the clinical research ...

Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch’s Substack ...

Shares of Cassava Sciences (NASDAQ: SAVA) were skyrocketing 29.6% higher as of 10:53 a.m. ET on Monday. The big gain came after executive chairman Rick Barry released an open letter to shareholders, ...

Buy rating: patented CXU platform & Ten-Minute Tissue targets FDA 510(k) by Q1 2027. See here for more details.

Developing medicines for tricky-to-treat conditions like Alzheimer's disease is tough under the best of circumstances, and as investors in Cassava Sciences (NASDAQ: SAVA) know, sometimes the ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Reporting favorable Q3 results on Monday evening, Exact Sciences is an intriguing stock to watch among the Zacks Rank #1 (Strong Buy) list. Recognized as a leader in medical diagnostics, the upside ...

The company plans to adopt the new name Saentra Forge S.p.A. and aims for majority ownership in companies generating up to approximately 5 million euros ($5.98 million) in EBITDA, starting with ATC, a ...

On Tuesday, Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping ...

Is Exact Sciences (NASDAQ: EXAS) about to go on a sustained run? The medical diagnostics specialist has lagged the market over the trailing-12-month period, but the stock is rebounding. In the past ...